
Research has shown that glucocorticoid administration has a significant beneficial effect for preterm births, as it decreases the incidence of respiratory distress syndrome in infants delivered between 24 weeks and 34 weeks gestation, reduces the incidence of intraventricular hemorrhage, improves circulatory stability in premature infants, reduces the need for oxygen and ventilatory support, and reduces overall neonatal mortality.







